#USA #New York #Class Action #Gross Law Firm #Iovance

Join the Class Action Against Iovance Biotherapeutics

The Gross Law Firm has issued a crucial announcement for shareholders of Iovance Biotherapeutics, Inc. (NASDAQ: IOVA). If you purchased shares between May 9, 2024, and May 8, 2025, it's vital to read this article thoroughly as your rights as an investor may be at stake.

Important Deadlines

Mark your calendars: July 14, 2025, is the last day to register for participation in this class action lawsuit. Shareholders who acted during the specified time frame are encouraged to contact the Gross Law Firm to determine eligibility for lead plaintiff status. Applying for lead plaintiff status is optional; even if you choose not to, you can still be involved in the recovery process.

Allegations Against Iovance Biotherapeutics

The basis of the lawsuit lies in allegations against Iovance, wherein the company purportedly provided investors with excessively positive information regarding its growth potential. Simultaneously, it is alleged that they concealed detrimental facts about their operational capabilities.

Particularly concerning is the announcement made on July 25, 2024. Iovance revealed a disappointing performance for the second quarter of fiscal 2024, leading to a reduction in revenue guidance for the entire year. They cited several factors contributing to this downturn, including scheduled maintenance of an important service center and disappointing Proleukin sales, which were below expectations. Furthermore, the inconsistent rate of patients beginning treatment at approved centers exacerbated the situation.

This news resulted in a staggering 44.8% drop in Iovance's common stock. On May 8, 2025, the shares closed at $3.17, only to plummet to $1.75 the following day, a severe loss that underlines the need for shareholders to take action quickly.

Next Steps for Shareholders

Once you register as a shareholder for the class action, you'll gain access to a portfolio monitoring system designed to provide you with updates regarding the lawsuit as it progresses. This service comes at no cost to you, ensuring that you remain informed and engaged in the legal proceedings surrounding your investment.

To sign up, visit the Gross Law Firm’s website and fill out the registration form linked above. It's crucial not to delay, as the July 14 deadline rapidly approaches.

Why Choose Gross Law Firm?

The Gross Law Firm stands as a well-respected figure in the realm of class action lawsuits, dedicated to safeguarding the rights of investors affected by fraudulent practices. They strive to ensure that companies operate honestly and transparently. If you have experienced financial losses as a result of misleading statements or undisclosed information from Iovance, this legal team is prepared to fight for your interests.

In conclusion, if you've held shares in Iovance Biotherapeutics within the outlined class period and wish to pursue justice and potential recovery for your losses, reach out to The Gross Law Firm before the nearing deadline. Your proactive approach can help not only you but also other impacted shareholders seek recourse for this distressing situation.

Don't wait; protect your rights today!